FDA Seeks Input on Teen Tobacco Snooping Survey Renewal
Published Date: 5/4/2026
Notice
Summary
The FDA wants your thoughts on continuing the National Youth Tobacco Survey, which checks how many young people use tobacco. This survey helps protect kids and teens by tracking tobacco habits and making smarter health rules. If you want to share your opinion, send your comments by July 6, 2026—no cost to you, just your voice!
Analyzed Economic Effects
4 provisions identified: 1 benefits, 3 costs, 0 mixed.
Parents May Need to Return Consent Forms
If your child is in grades 6–12, parents or guardians may need to complete an active consent form for the National Youth Tobacco Survey. FDA estimates 3,500 parents will be asked to spend about 10 minutes each (total 595 hours) to return these forms for the 2027–2029 survey period.
Students Will Take a 45-Minute Digital Survey
Students in grades 6–12 will be asked to take an anonymous, web-based tobacco survey that takes about 45 minutes. FDA estimates 29,575 student questionnaire responses for 2027–2029, totaling about 22,181 hours of student response time.
Overall Respondent Burden Will Rise
For the 2027–2029 NYTS, FDA estimates the overall respondent burden increases by 1,108 hours and 4,313 responses compared with the prior period. FDA reports a total annual burden of 23,708 hours across all respondent types for this information collection.
No Direct Money Costs to Respondents
FDA states there are no capital costs or operating and maintenance costs associated with this information collection, so respondents will not face direct monetary charges. You are asked only to provide information or return consent forms by the July 6, 2026 comment date if you want to comment on the collection.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20063, Request for Nominations for Voting Members of Food and Drug Administration Advisory Committees
The FDA is looking for smart, qualified people to join its advisory committees and help make important decisions about food and drugs. If you have the right skills, you can apply anytime, but get your nomination in by November 30, 2026, for the best chance at current openings. This is a great chance to influence public health without any cost to you!
Previous / Next Documents
Previous: 2026-08602, Investigative Hearing
A tragic UPS cargo plane crash in Louisville killed 14 people and injured many more, sparking a big public hearing on May 19-20, 2026. The hearing will dig into airplane safety, design rules, and how the FAA and Boeing handle safety issues. This affects airlines, manufacturers, and passengers, aiming to boost safety and prevent future accidents.
Next: 2026-08606, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on grant applications related to aging, genetics, neurodegeneration, and pediatric critical care. These meetings are private to protect sensitive information and personal privacy. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve new costs or changes to the process.